CHRS · Coherus Oncology, Inc. · Proposed Sales
$0.77
+0.02 (+2.82%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$118.97M
Shares
154.50M
Volume · Nov 6
1.08M
Avg daily vol (3M)
1.45M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Key facts
CIK
1512762
CUSIP
19249H103
13F (30d)
72 filings
49 filers
Visit website
Investor relations